NCT05388942

Brief Summary

Anterior shoulder dislocation (ASD) is a common situation in the emergency department (ED). Quick reductions lead to reduced mid and long term complications. No technique is superior to one another. Inhaled nitrous oxide can deal with pain reduction and anxiety but its efficacy is not optimal, with safety issues. Virtual reality hypnosis (VRH), by distracting patients from their pain, may lead to a better muscular relaxation and an easier ASD reduction. Our first objective is to evaluate the clinical interest of VHR compared to nitrous oxide, in ASD reduction. Our second objective is to evaluate the safety of VRH in ASD reduction. Patients over 18 years presenting an ASD \< 24 hours, will be illegible for enrollment in an open multicenter randomized controlled trial, conducted in the Great East Region in France.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 24, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

October 9, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 9, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 9, 2024

Completed
Last Updated

February 23, 2023

Status Verified

February 1, 2023

Enrollment Period

1 year

First QC Date

May 19, 2022

Last Update Submit

February 22, 2023

Conditions

Keywords

shoulder dislocationvirtual realityhypnosis

Outcome Measures

Primary Outcomes (1)

  • Reduction of ASD procedure time

    Day 0

Secondary Outcomes (6)

  • Achievement of the reduction of ASD procedure

    Day 0

  • Per-procedure pain

    Day 0

  • Passage time in the ED

    Day 0

  • Patient satisfaction

    Day 0

  • Adverse events when using HRV

    Day 0

  • +1 more secondary outcomes

Study Arms (2)

Virtual reality hypnosis (VRH)

EXPERIMENTAL
Procedure: Virtual reality hypnosis

Nitrous oxide (NO)

ACTIVE COMPARATOR
Drug: Nitrous oxide

Interventions

VRH offers predefined hypnosis sessions with no need of trained physician or nurse or caregiver mobilization. Consisting of a headset including headphones and a virtual reality screen, VRH allow patients to select a visual and sound environment (e.g.: tropical beach, space, underwater…) into which the hypnotic speech is delivered. That way, the patient's attention is distracted and muscular relaxation is obtained, a major relaxation factor. HRV is simple, quick, and presumably safe.

Virtual reality hypnosis (VRH)

inhalation of NO usually used to help with ASD reduction but inhaled NO has safety and maintenance issues.

Nitrous oxide (NO)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients of 18 years and older
  • consulting the ED for a ASD \< 24 hours
  • with or without history of ASD
  • with social insurance

You may not qualify if:

  • non anterior shoulder dislocation
  • shoulder or facial fracture or multiple trauma patient
  • dementia, psychosis
  • uncontrolled epilepsy
  • visual or hearing issues
  • claustrophobia
  • vascular or nervous lesion of the dislocated arm
  • contraindication with the use of inhaled nitrous oxide

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

RECRUITING

MeSH Terms

Conditions

Shoulder Dislocation

Interventions

Nitrous Oxide

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesShoulder Injuries

Intervention Hierarchy (Ancestors)

Nitrogen OxidesGasesInorganic ChemicalsNitrogen CompoundsOxidesOxygen Compounds

Central Study Contacts

Stéphane GENNAI

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2022

First Posted

May 24, 2022

Study Start

October 9, 2022

Primary Completion

October 9, 2023

Study Completion

January 9, 2024

Last Updated

February 23, 2023

Record last verified: 2023-02

Locations